- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
TheStreet's Adam Feuerstein lays down his predictions for the biotech industry for 2015.
I can't remember the last time a company got more than a slap on the wrist.
Trade-Ideas LLC identified Questcor Pharmaceuticals (QCOR) as a new lifetime high candidate